Bladder Cancer Advocacy Network
The network John and Diane Quale founded in 2005, when bladder cancer research was in its infancy and there was no clear career path for scientists in the field, now running the field's annual Think Tank, its ladder of research awards and its case in Washington, for patients and for the researchers it set out to create.
Financial profile
Bladder Cancer Advocacy Network Inc · EIN 20-2897110 · 501(c)(3)
| Fiscal year | Total revenue | Contributions | Program services | Total expenses | Net assets | Year end |
|---|---|---|---|---|---|---|
| FY2025 | $6,772,678 | $6,672,233 | $65,921 | $7,014,426 | $14,885,203 | Dec 2025 |
| FY2024 | $6,370,229 | $5,941,393 | $52,968 | $6,105,896 | $14,461,960 | Dec 2024 |
| FY2023 | $5,449,892 | $5,143,510 | $52,825 | $5,881,727 | $13,492,007 | Dec 2023 |
| FY2022 | $8,907,201 | $8,752,305 | $36,265 | $4,075,708 | $13,281,983 | Dec 2022 |
| FY2021 | $4,308,947 | $4,287,920 | $20 | $3,306,731 | $8,848,883 | Dec 2021 |
| FY2020 | $4,801,294 | $4,644,432 | $111,940 | $2,597,124 | $7,768,539 | Dec 2020 |
Figures exactly as reported. A blank cell was blank on the form. The fiscal year links to the filing.
Peer societies
Five societies BCAN is read alongside.
PCF
Prostate Cancer Foundation
A national funder working since 1993 to end death and suffering from prostate cancer, financing research…
12 companies named
RAN
Research Advocacy Network
A training force that turns patient advocates into full contributors to cancer research
MRA
Melanoma Research Alliance
The world's largest private nonprofit funder of melanoma research, structured so every donated dollar reaches…
140 companies named
INF
The IBC Network Foundation
A patient led drive to fund research and gather people around a neglected breast cancer
SFA
Sarcoma Foundation of America
The organization Jeffrey Thornton's parents and Dr. Jack Brooks started in a family basement in 2000 after…
21 companies named
Who backs BCAN
Every company BCAN names publicly as a supporter, exactly as published. Companies also named by other associations on Sociogene come first.
| Company | Support as published | Also named by |
|---|---|---|
| AstellasPublished as Astellas (Astellas | Pfizer alliance logo) | Corporate partner | ARM AAO AAPA AACR AOA +3 |
| AstraZeneca | Corporate partner | AMCP AAAAI AAFP AAN AAPA +3 |
| Bristol Myers Squibb | Corporate partner | AMCP ARM AAD AAN AAPMR +3 |
| Daiichi Sankyo | Corporate partner | AACR ACS AOSSM ASRO ASCO +3 |
| EMD Serono | Corporate partner | AANEM ACR AOSSM ASRO ASRM +3 |
| Ferring PharmaceuticalsPublished as Ferring | Corporate partner | ACG ASRM IDSA MCCC SMFM +3 |
| Genentech | Corporate partner | AMCP AcademyHealth AAAAI AAFP AAN +3 |
| Johnson & Johnson | Corporate partner | AMCP AcademyHealth ACS AEE AAD +3 |
| Lilly | Corporate partner | AMCP AAAAI AAFP AAPA AASM +3 |
| Merck | Corporate partner | AcademyHealth AEE AAFP AAO AAP +3 |
| Natera | Corporate partner | AASLD AATS AAES ACMGG ACNM +3 |
| PfizerPublished as Pfizer (Astellas | Pfizer alliance logo) | Corporate partner | AEE ASCA AAD AAFP AAN +3 |
| ImmunityBio | Corporate partner | IASLC SUO |
| Tyra BiosciencesPublished as Tyra | Corporate partner | ACMGG PES |
| enGene | Corporate partner | SUO |
| Protara Therapeutics | Corporate partner | SUO |
| UroGen PharmaPublished as UroGen | Corporate partner | SUNA |
| CG Oncology | Corporate partner | Only BCAN, so far |
| Flare Therapeutics | Corporate partner | Only BCAN, so far |
| Photocure | Corporate partner | Only BCAN, so far |
| Relmada Therapeutics | Corporate partner | Only BCAN, so far |
Sources: 2 published lists, read October 2026
2026 Bladder Cancer Think Tank Meeting: Think Tank Title Sponsor Speakers. Read October 7, 2026. Companies presenting as title sponsors at the 2026 Bladder Cancer Think Tank in Denver.
Partners and Sponsors. Read October 7, 2026. Companies BCAN thanks as corporate partners for support of its events, programs and research.
Who backs BCAN's peers, but not BCAN
Companies named publicly by at least one of BCAN's five peer societies, and not found in BCAN's reviewed public records.
| Company | PCF | MRA | SFA | Peers |
|---|---|---|---|---|
| Novartis | Named | Named | 2 of 3 | |
| 26 North | Named | 1 of 3 | ||
| Aadi BiosciencePublished as AADI | Named | 1 of 3 | ||
| AbbVie | Named | 1 of 3 | ||
| Adaptimmune | Named | 1 of 3 | ||
| Agenus | Named | 1 of 3 | ||
| Alice + Olivia | Named | 1 of 3 | ||
| Alpine Investors | Named | 1 of 3 | ||
| American Industrial Partners | Named | 1 of 3 | ||
| Antares Capital | Named | 1 of 3 | ||
| Apax Partners | Named | 1 of 3 | ||
| Apollo | Named | 1 of 3 | ||
| Ares Management | Named | 1 of 3 | ||
| Atlanta Hawks | Named | 1 of 3 | ||
| Audax Private Debt | Named | 1 of 3 | ||
| Bank of AmericaPublished as BOA | Named | 1 of 3 | ||
| BayerPublished as Bayer Pharmaceuticals | Named | 1 of 3 | ||
| BC Partners | Named | 1 of 3 | ||
| Benefit Street Partners | Named | 1 of 3 | ||
| Bimini Bay OutfittersPublished as Bimini-Bay | Named | 1 of 3 | ||
| BlackRock | Named | 1 of 3 | ||
| BlackstonePublished as Blackstone Group LP | Named | 1 of 3 | ||
| Blue Owl Capital | Named | 1 of 3 | ||
| BMO Capital Markets | Named | 1 of 3 | ||
| Boehringer Ingelheim | Named | 1 of 3 | ||
| Bonanza CasinoPublished as Bonanza | Named | 1 of 3 | ||
| Brigade Capital Management | Named | 1 of 3 | ||
| Brinley Partners | Named | 1 of 3 | ||
| Brownstein Hyatt Farber SchreckPublished as Brownstein, Hyatt, Farber & Schreck | Named | 1 of 3 | ||
| Cahill Gordon & Reindel | Named | 1 of 3 | ||
| Castle BiosciencesPublished as Castle | Named | 1 of 3 | ||
| ChevronPublished as Chevron Matching Gifts | Named | 1 of 3 | ||
| Citi | Named | 1 of 3 | ||
| ClaudentPublished as CLDNT | Named | 1 of 3 | ||
| Clifford Chance | Innovator Sponsors | 1 of 3 | ||
| Cozen O'Connor | Innovator Sponsors | 1 of 3 | ||
| CURE | Named | 1 of 3 | ||
| CVC Capital Partners | Named | 1 of 3 | ||
| Davis Polk & Wardwell | Named | 1 of 3 | ||
| Debevoise & Plimpton | Named | 1 of 3 | ||
| Deciphera | Benefactor Sponsors | 1 of 3 | ||
| DermTech | Named | 1 of 3 | ||
| DLA Piper | Named | 1 of 3 | ||
| Evolution Credit PartnersPublished as Evolution Credit Partners Management, LLC | Named | 1 of 3 | ||
| Exact SciencesPublished as Exact Sciences Laboratories LLC | Named | 1 of 3 | ||
| Fidelity Brokerage Services | Named | 1 of 3 | ||
| Fitch RatingsPublished as Fitch-raitings | Named | 1 of 3 | ||
| Fortinbras Enterprises | Named | 1 of 3 | ||
| Foundation Medicine | Named | 1 of 3 | ||
| Fox Sports | Named | 1 of 3 | ||
| Franklin Templeton Investments | Named | 1 of 3 | ||
| Freshfields Bruckhaus Deringer USPublished as Freshfields Bruckhaus Deringer LLP | Named | 1 of 3 | ||
| Fried, Frank, Harris, Shriver & Jacobson | Named | 1 of 3 | ||
| General Atlantic | Named | 1 of 3 | ||
| Gibson, Dunn & Crutcher | Named | 1 of 3 | ||
| Giles Enterprises | Named | 1 of 3 | ||
| GoldenTree Asset Management | Named | 1 of 3 | ||
| Goldman SachsPublished as Goldman | Named | 1 of 3 | ||
| Golub Capital | Named | 1 of 3 | ||
| Goodwin Procter | Named | 1 of 3 | ||
| Greenberg Traurig | Hope Sponsors | 1 of 3 | ||
| GTCR | Named | 1 of 3 | ||
| Guggenheim Partners | Named | 1 of 3 | ||
| Hellman & Friedman | Named | 1 of 3 | ||
| Holland & KnightPublished as HollandKnight | Named | 1 of 3 | ||
| HPS Investment PartnersPublished as HPS | Named | 1 of 3 | ||
| HSBC Bank | Named | 1 of 3 | ||
| iHeartRadio | Named | 1 of 3 | ||
| Immunocore | Named | 1 of 3 | ||
| Immunome | Innovator Sponsors | 1 of 3 | ||
| Independence Blue Cross | Named | 1 of 3 | ||
| Intermediate Capital Group | Named | 1 of 3 | ||
| Investcorp | Named | 1 of 3 | ||
| IO Biotech | Named | 1 of 3 | ||
| Iovance | Named | 1 of 3 | ||
| Iovance Biotherapeutics | Named | 1 of 3 | ||
| Jefferies Financial Group | Named | 1 of 3 | ||
| JT Magen | Benefactor Sponsors | 1 of 3 | ||
| KenvuePublished as JJ-new-name-kenvue | Named | 1 of 3 | ||
| Khaite | Named | 1 of 3 | ||
| Kimberly-Clark | Named | 1 of 3 | ||
| King & Spalding | Named | 1 of 3 | ||
| Kirkland & EllisPublished as KirklandEllis | Named | 1 of 3 | ||
| KKRPublished as Kohlberg Kravis Roberts & Co. | Named | 1 of 3 | ||
| L'OrealPublished as LOreal-ACD | Named | 1 of 3 | ||
| L'Oreal Paris | Named | 1 of 3 | ||
| Latham & WatkinsPublished as Latham-Watkins | Named | 1 of 3 | ||
| Leonard Green & Partners | Named | 1 of 3 | ||
| Linklaters | Named | 1 of 3 | ||
| Macquarie Group | Named | 1 of 3 | ||
| Madison Dearborn Partners | Named | 1 of 3 | ||
| Major League BaseballPublished as MLB | Named | 1 of 3 | ||
| Max Mara | Named | 1 of 3 | ||
| Mayer Brown | Named | 1 of 3 | ||
| Melan SuncarePublished as melan-logo | Named | 1 of 3 | ||
| Merrill LynchPublished as Merrill Lynch, Pierce, Fenner & Smith Inc. | Named | 1 of 3 | ||
| Microsoft | Named | 1 of 3 | ||
| MidOcean Partners | Named | 1 of 3 | ||
| Milbank | Named | 1 of 3 | ||
| Milwaukee Brewers | Named | 1 of 3 | ||
| Mizuho Securities USA | Named | 1 of 3 | ||
| MJX Asset Management | Named | 1 of 3 | ||
| Moderna | Named | 1 of 3 | ||
| Moran Insurance | Named | 1 of 3 | ||
| Morgan Stanley | Named | 1 of 3 | ||
| Morrison Foerster | Discovery Sponsors | 1 of 3 | ||
| MUFGPublished as Mitsubishi UFJ Financial Group, Inc. (MUFG) | Named | 1 of 3 | ||
| Mural Oncology | Named | 1 of 3 | ||
| MV Credit Partners | Named | 1 of 3 | ||
| Natixis | Named | 1 of 3 | ||
| Nella Holdings | Named | 1 of 3 | ||
| NeraCare | Named | 1 of 3 | ||
| Network Financial PrintingPublished as NFP | Named | 1 of 3 | ||
| New Mountain Capital | Named | 1 of 3 | ||
| New York PostPublished as nypost.com | Named | 1 of 3 | ||
| O'Melveny | Innovator Sponsors | 1 of 3 | ||
| O'Melveny & Myers | Named | 1 of 3 | ||
| Oak Hill Capital Management | Named | 1 of 3 | ||
| Obsidian TherapeuticsPublished as obsidian | Named | 1 of 3 | ||
| Overland & Shanahan | Named | 1 of 3 | ||
| Parabilis MedicinesPublished as Parabilis | Innovator Sponsors | 1 of 3 | ||
| Paul Hastings | Named | 1 of 3 | ||
| Paul, Weiss | Innovator Sponsors | 1 of 3 | ||
| Paul, Weiss, Rifkind, Wharton & GarrisonPublished as Paul, Weiss, Rifkin, Wharton & Garrison LLP | Named | 1 of 3 | ||
| Perella Weinberg Partners | Named | 1 of 3 | ||
| Piper Sandler | Benefactor Sponsors | 1 of 3 | ||
| PlayStationPublished as PlayStation Cares | Named | 1 of 3 | ||
| PNC Bank | Named | 1 of 3 | ||
| PRIME Education | Named | 1 of 3 | ||
| Prophet Solutions | Named | 1 of 3 | ||
| Proskauer Rose | Named | 1 of 3 | ||
| Raymond James Investment Banking | Named | 1 of 3 | ||
| Rayward Apparel | Named | 1 of 3 | ||
| Regeneron | Named | 1 of 3 | ||
| Replimune | Named | 1 of 3 | ||
| Reuzel | Named | 1 of 3 | ||
| Ropes & Gray | Named | 1 of 3 | ||
| Salty Weapon | Named | 1 of 3 | ||
| Scotiabank | Named | 1 of 3 | ||
| Servier | Discovery Sponsors | 1 of 3 | ||
| Sidley Austin | Named | 1 of 3 | ||
| Silver Rock Financial | Named | 1 of 3 | ||
| Simpson Thacher & BartlettPublished as Simpson | Named | 1 of 3 | ||
| SkinCeuticalsPublished as Skinc | Named | 1 of 3 | ||
| Sol Labs | Named | 1 of 3 | ||
| Sony Music Entertainment | Named | 1 of 3 | ||
| SpringWorks TherapeuticsPublished as Springworks | Hope Sponsors | 1 of 3 | ||
| Stone Canyon Industries | Named | 1 of 3 | ||
| Stone Point Capital | Named | 1 of 3 | ||
| Stryker | Named | 1 of 3 | ||
| Sullivan & Cromwell | Named | 1 of 3 | ||
| Sundercover | Named | 1 of 3 | ||
| Tecta America | Named | 1 of 3 | ||
| The Carlyle Group | Named | 1 of 3 | ||
| Thoma Bravo | Named | 1 of 3 | ||
| ToadfishPublished as TF-Logo / toadfish.com | Named | 1 of 3 | ||
| TPG Angelo Gordon | Named | 1 of 3 | ||
| U.S. Bank | Named | 1 of 3 | ||
| UBS | Named | 1 of 3 | ||
| UBS Investment Bank | Named | 1 of 3 | ||
| US WorldMeds | Hope Sponsors | 1 of 3 | ||
| Veritas CapitalPublished as Veritas | Named | 1 of 3 | ||
| Vintage Financial Partners | Benefactor Sponsors | 1 of 3 | ||
| Warburg Pincus | Named | 1 of 3 | ||
| Weil, Gotshal & Manges | Named | 1 of 3 | ||
| White & CasePublished as white-case | Named | 1 of 3 |
The outside view
The network John and Diane Quale founded in 2005, when bladder cancer research was in its infancy and there was no clear career path for scientists in the field, now running the field's annual Think Tank, its ladder of research awards and its case in Washington, for patients and for the researchers it set out to create.
- Authority
- Build
- Outward
- Operational
Their shape
The Frontier
At home at the edge of what comes next.
The Frontier is restless and pioneering, always testing what comes next. Its gift is innovation and adaptability, its challenge is focus, and not leaving its longtime members behind.
Also reads toward The Guild and The Movement.
Strengths
Not an official page of Bladder Cancer Advocacy Network. Sociogene does not consult. Everything here comes from public sources, dated and linked. Something wrong here? Tell us what we missed.